Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Lancet ; 1(7911): 832-5, 1975 Apr 12.
Article in English | MEDLINE | ID: mdl-48058

ABSTRACT

Four patients with homozygous hyperbetalipoproteinaemia who had proved resistant to intensive medical therapy have undergone portacaval shunt. During 3 weeks of total parenteral alimentation before the operation, the serum-cholesterol decreased significantly in each of the four patients. During the fat-emulsion phase of hyperalimentation, one patient experienced a rise in cholesterol. Postoperatively, the size of xanthomas decreased in all cases; serum-cholesterol levels rose above those achieved during hyperalimentation, and this rise continued for as long as 3 months before a further reduction was recorded. In patients with angina, this improved considerably; and in most cases bruits decreased in itensity. The results at this stage do not, however, suggest portacaval shunt for all patients with homozygous hypercholesterolaemia.


Subject(s)
Hypercholesterolemia/therapy , Portacaval Shunt, Surgical , Adolescent , Adult , Child , Cholesterol/blood , Cholestyramine Resin/therapeutic use , Clofibrate/therapeutic use , Dietary Fats/administration & dosage , Female , Glucose/therapeutic use , Homozygote , Humans , Hypercholesterolemia/blood , Hypercholesterolemia/genetics , Infant , Infant, Newborn , Male , Middle Aged , Nicotinic Acids/therapeutic use , Parenteral Nutrition , Pedigree , Preoperative Care , Protein Hydrolysates/therapeutic use , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...